EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Efficacy and safety of dexamethasone and prednisone for therapy in childhood acute lymphoblastic leukemia: A systematic review and meta-analysis

Wenqiong Lv, Dongjun Li, Jianhua Li, Yao Xie, Xue Yang

Clinical and Investigative Medicine · 01.07.2026 · 49 (2) · 43-55

DOI: 10.3138/cim-2025-0188 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical and Investigative Medicine, erschienen am 01.07.2026. Verfasst von Wenqiong Lv und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Dexamethasone, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Prednisone. Die Arbeit nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This meta-analysis examined the efficacy and safety of dexamethasone compared with prednisone in the treatment of acute lymphoblastic leukemia (ALL).

Methods

A search was conducted in PubMed, EMBASE, and the Cochrane Library databases for randomized controlled trials (RCTs) or observational studies involving children diagnosed with ALL who received dexamethasone or prednisone as pharmacotherapy. Studies without access to primary data were excluded. RCTs were assessed using the Cochrane Risk of Bias 2.0 tool, while observational studies were evaluated with ROBINS-I.

Results

Fourteen studies involving 12,665 children were analyzed. Dexamethasone significantly improved event-free survival compared to prednisone (OR 1.40 [95% CI 1.26 to 1.56], P < 0.001). However, the pooled results, which showed significant heterogeneity, indicated a potentially higher incidence of toxicity associated with dexamethasone (OR 1.92 [95% CI 1.32 to 2.81]), a finding that warrants cautious interpretation. Qualitative synthesis further clarified that this increased risk was particularly evident for infectious, neuropsychiatric, and musculoskeletal adverse events. No significant differences were found in remission rates, relapse rates, or mortality between the two glucocorticoids. The GRADE assessment indicated high certainty regarding the evidence for event-free survival.

Conclusions

In children with ALL, dexamethasone improves event-free survival compared to prednisone but may have a higher risk of adverse effects. This highlights the need for a careful benefit-risk assessment. Future research should explore hybrid glucocorticoid strategies to maximize survival outcomes while reducing adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasonePrecursor Cell Lymphoblastic Leukemia-LymphomaPrednisoneHumansChildTreatment OutcomeDisease-Free Survival

Stichwörter der Autor:innen

acute lymphoblastic leukemiadexamethasonemeta-analysisprednisonesurvival

Substanzen

DexamethasonePrednisone

Autor:innen und Institutionen

  • Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, Sichuan, China.
  • Department of Obstetrics and Gynaecology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Zitieren

APA

Lv, W., Li, D., Li, J., Xie, Y., & Yang, X. (2026). Efficacy and safety of dexamethasone and prednisone for therapy in childhood acute lymphoblastic leukemia: A systematic review and meta-analysis. Clinical and Investigative Medicine, 49(2), 43-55. https://doi.org/10.3138/cim-2025-0188

Vancouver

Lv W, Li D, Li J, Xie Y, Yang X. Efficacy and safety of dexamethasone and prednisone for therapy in childhood acute lymphoblastic leukemia: A systematic review and meta-analysis. Clinical and Investigative Medicine. 2026;49(2):43-55. doi:10.3138/cim-2025-0188

BibTeX
@article{Lv2026,
  author = {Lv, Wenqiong and Li, Dongjun and Li, Jianhua and Xie, Yao and Yang, Xue},
  title = {Efficacy and safety of dexamethasone and prednisone for therapy in childhood acute lymphoblastic leukemia: A systematic review and meta-analysis},
  journal = {Clinical and Investigative Medicine},
  year = {2026},
  volume = {49},
  number = {2},
  pages = {43--55},
  doi = {10.3138/cim-2025-0188}
}
Kostenlos starten →